Financials
- Market Capitalization 482.15 M
- Employee 17
- Founded 2004
- CEO N/A
- Website www.relmada.com
- Headquarter Nevada, United States
- FIGI BBG003MKSL16
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-3.33
Fiyat/satışlar oranı
-2 407.45
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 2918 | CCCC C4 Therapeutics, Inc. - Common Stock | 4.10 USD | -3.30% | 0.00% | +18.84% | +62.06% | 504.40 M USD | ||
| 2939 | EVMN Evommune, Inc. Common Stock | 13.43 USD | -4.95% | -2.61% | +20.88% | -22.46% | 487.40 M USD | ||
| 2956 | RZLT Rezolute, Inc. - Common Stock | 4.98 USD | -1.19% | +6.18% | +1.01% | -31.69% | 479.54 M USD | ||
| 2957 | PBYI Puma Biotechnology Inc - Common Stock | 9.24 USD | +0.87% | -0.22% | +16.08% | +83.70% | 476.97 M USD |